Signals From [Space]的动态

Welcome back, we’ve missed you. This is our first update of 2025, and it was a fun one to bring together. A new year means new funding, new research, new jobs, and even a new look for us here at?Signals?HQ. There are?two changes?you can expect from our recaps going forward: (1) they’ll be more?consistent?(Sundays, not anydays); and (2) they’ll be more?to the point?(five or ten minutes, not fifty). To support these changes, we’re tidying up our format. We’ll focus on the 2-3 stories you should know about and why they matter, followed by curated lists of headlines, research, community updates and open roles across the Kidneyverse. This is our first test run, so your feedback is important here. I’d love to hear from you. Leave a comment, send me a DM, or?join us in Signals Slack?to let me know what you think of the new format, cadence, and branding. Let’s light this candle, shall we???? What's inside this edition: Alex Azar, CMMI, CMS, Carilion Clinic, Interwell Health, Monogram Health, Roanoke Memorial Hospital, Miriam Godwin, Alice Wei, M.D., Ann Kempski, Liise Kayler, MD, MS, FACS, TransMedics, Inc., Novo Nordisk, Maze Therapeutics, Metsera, Abe Sutton, Paul D Gordon, National Kidney Foundation, Fresenius Group, 34 Lives. Rory Caswell Pace, MPH, RD, CSR, FAND, FNKF, Piedmont, Novartis, Diality *** As a reminder, these LinkedIn posts are just previews and go out less often than the full newsletter and media platform. If you want to read this full post (for free) and get the most up-to-date insights and analysis on all things kidney, subscribe to Signals here: ?? trfitzpatrick.com/welcome ??